Bev Acreman is appointed Commercial Director of F1000

Announcement discussing Bev Acreman's new post as Commercial Director of F1000:

"Bev, who will take up the post at the beginning of April, was formerly Vice President of Marketing & Sales, Open Research, at Springer Nature – a global research, educational and professional publisher. At Springer Nature, part of Bev’s role included a focus on collaborating with Chinese funders and universities to build a solid infrastructure and understanding of Open Access in this hugely important scientific market. She has spoken at Chinese conferences organised by the Chinese Academy of Sciences (CAS) and Chinese Association for Science and Technology (CAST). She also set up and ran the inaugural Open Access Asia (OASPA) conference in Bangkok in 2014. Prior to that, Bev headed up the commercial division at the first open access publisher, BioMed Central, where she built up its international sales, marketing and customer service teams Bev is currently on the board of UKSG. She has served as a committee chair for the STM Association and recently joined the Directory of Open Access Journals’ (DOAJ) advisory committee. Rebecca Lawrence, managing director of F1000, said: “Bev has extensive experience in marketing and sales, both in open access publishing and in the development of tools to help researchers manage references and ultimately write articles. “We are delighted to welcome her to F1000 where she will play a key role in helping us to drive much-needed change in the way that new findings are shared and researchers are evaluated.” Bev said: “It is an exciting time to be joining F1000: there are major changes underway in the communication of scientific research and F1000 is determined to lead these changes – through post publication peer review in F1000Research, the new F1000Workspace, and the respected F1000Prime article recommendations by the F1000 Faculty.”